sorafenib has been researched along with pd 198306 in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (pd 198306) | Trials (pd 198306) | Recent Studies (post-2010) (pd 198306) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 7 | 0 | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, X; Hong, J; Zheng, W | 1 |
1 other study(ies) available for sorafenib and pd 198306
| Article | Year |
|---|---|
Small-molecule High-throughput Screening Identifies an MEK Inhibitor PD198306 that Enhances Sorafenib Efficacy via MCL-1 and BIM in Hepatocellular Carcinoma Cells.
Topics: Antineoplastic Agents; Apoptosis; Bcl-2-Like Protein 11; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; High-Throughput Screening Assays; Humans; Liver Neoplasms; Mitogen-Activated Protein Kinase Kinases; Myeloid Cell Leukemia Sequence 1 Protein; Protein Kinase Inhibitors; Sorafenib | 2023 |